| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Roscovitine | FIMM | pan-cancer | AAC | 0.047 | 0.8 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |